Page last updated: 2024-08-23

atomoxetine hydrochloride and Asperger Disease

atomoxetine hydrochloride has been researched along with Asperger Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Maynard, M; McDougle, CJ; Posey, DJ; Stigler, KA; Wiegand, RE; Wilkerson, J	1

Other Studies

1 other study(ies) available for atomoxetine hydrochloride and Asperger Disease

Article	Year
Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:5 Topics: Adolescent; Adrenergic Uptake Inhibitors; Asperger Syndrome; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Body Weight; Child; Child Development Disorders, Pervasive; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intelligence; Irritable Mood; Male; Neuropsychological Tests; Pilot Projects; Propylamines; Prospective Studies; Treatment Outcome	2006

Article

Year

Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.

Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:5

Topics: Adolescent; Adrenergic Uptake Inhibitors; Asperger Syndrome; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Body Weight; Child; Child Development Disorders, Pervasive; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intelligence; Irritable Mood; Male; Neuropsychological Tests; Pilot Projects; Propylamines; Prospective Studies; Treatment Outcome

2006